EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Viral etiology of severe acute respiratory infections in hospitalized patients, Shandong, China

Chunwang Li, Yujie He, Xiao Pan, Huimin Yin, Yaowen Pei, Shaoxia Song, Lin Sun, Shu Zhang, Julong Wu, Zhong Li, Xianjun Wang, Zengqiang Kou und 3 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0328439 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS One, 2025. Verfasst von Chunwang Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Shandong First Medical University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Respiratory Tract Infections. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Medical and Health Science and Technology Project, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe Acute Respiratory Infection (SARI) represents a critical global public health challenge, accounting for substantial severe morbidity and hospitalization burdens with distinct geographical patterns in etiological profiles. This study systematically characterizes the epidemiological and clinical phenotypes of SARI patients in Shouguang county, Shandong Province, China.

Methods

A prospective observational study was conducted at Shouguang People’s Hospital between August 28, 2023 and April 30, 2024, enrolling 1,730 hospitalized patients with SARI from the Departments of Infectious Diseases and Respiratory and Critical Care Medicine. Standardized electronic case report forms were used to systematically collect the demographic characteristics, clinical manifestations and laboratory testing results. Oropharyngeal swab specimens were collected within 24 hours of admission for each patient and stored at −80°C. Multiplex real-time quantitative PCR (RT-qPCR) was performed using the ABI 7500 system to detect 11 respiratory viruses infection, including influenza A virus (IFA), influenza B virus (IFB), respiratory syncytial virus (RSV), parainfluenza virus (HPIV), human coronaviruses (HCoV), human metapneumovirus (HMPV), rhinovirus (HRV), enterovirus (EV), human bocavirus (HBoV), human adenovirus (HAdV), and SARS-CoV-2 (COVID-19).

Results

501 samples (28.96%) were tested positive for at least one virus. The most frequently detected viruses and their infection rates were as follows: IFA (11.33%), COVID-19 (6.53%), HPIV (2.31%), HCoV (2.20%), RSV (1.79%), IFB (1.68%), HMPV (1.56%), EV (0.64%), HADV (0.52%), and HBoV (0.06%). Among patients aged 0–14 years, IFA and EV had the highest infection rates, both at 9.46% (7/74). In the 15–24 age group, IFA exhibited the highest infection rate at 19.70% (26/132). In patients aged ≥70 years, COVID-19 was the most frequently detected virus, with a infection rate of 10.69% (65/608). The overall virus infection rate peaked at 60.00% (30/50) in epidemiological week 48 of 2023. During weeks 46–50 of 2023, the overall infection rate remained consistently high (range: 28.42–60.00%). Significant differences in infection rates were observed across hospital departments (χ² = 5.52, P < 0.05), The Department of Infectious Diseases demonstrated a higher infection rate of 34.91% (162/464) compared to 29.07% (368/1266) in the Department of Respiratory Medicine.

Conclusion

Viral etiological analysis of SARI patients in Eastern China identified IFA, COVID-19, and HPIV as the three predominant virus, with influenza virus exhibiting the highest frequency of co-infection with other respiratory viruses. Our study further revealed significant heterogeneity in virus distribution across different hospital departments, age groups, and admission periods. The most common clinical manifestations were cough and fever, with distinct symptomatic profiles observed among infections caused by different viruss. These findings provide scientific evidence to inform government strategies for optimizing the prevention and management of respiratory infectious diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Tract InfectionsHumansChinaFemaleMaleMiddle AgedAdultChild, PreschoolChildAgedInfantHospitalizationAdolescentProspective StudiesYoung AdultInfant, NewbornAged, 80 and overCOVID-19Acute Disease

Autor:innen und Institutionen

  • School of Public Health, Shandong First Medical University, Jinan, Shandong, China.
  • Shandong Center for Disease Control and Prevention, Shandong Institute of Preventive Medicine, Shandong Provincial Key Laboratory of Intelligent Monitoring, Early Warning, and Prevention of Infectious Diseases (in prepa…
  • Shandong Institute of Parasitic Disease Control, Shandong First Medical University (Shandong Academy of Medical Sciences), Jining, Shandong, China.
  • School of Public Health, Shandong Second Medical University, Weifang, Shandong, China.
  • Shouguang Center for Disease Control and Prevention, Weifang, Shandong, China.

ORCID-Profile: Ti Liu

Förderung

  • Shandong Medical and Health Science and Technology Project
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Li, C., He, Y., Pan, X., Yin, H., Pei, Y., Song, S., Sun, L., Zhang, S., Wu, J., Li, Z., Wang, X., Kou, Z., Zhao, L., Xing, W., & Liu, T. (2025). Viral etiology of severe acute respiratory infections in hospitalized patients, Shandong, China. PLOS One. https://doi.org/10.1371/journal.pone.0328439

Vancouver

Li C, He Y, Pan X, Yin H, Pei Y, Song S, et al. Viral etiology of severe acute respiratory infections in hospitalized patients, Shandong, China. PLOS One. 2025. doi:10.1371/journal.pone.0328439

BibTeX
@article{Li2025,
  author = {Li, Chunwang and He, Yujie and Pan, Xiao and Yin, Huimin and Pei, Yaowen and Song, Shaoxia and Sun, Lin and Zhang, Shu and Wu, Julong and Li, Zhong and Wang, Xianjun and Kou, Zengqiang and Zhao, Lei and Xing, Weijia and Liu, Ti},
  title = {Viral etiology of severe acute respiratory infections in hospitalized patients, Shandong, China},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0328439}
}
Kostenlos starten →